APLT
Price
$1.15
Change
+$0.01 (+0.88%)
Updated
Oct 14 closing price
Capitalization
165.61M
22 days until earnings call
Intraday Buy/Sell Signals
KALA
Price
$1.51
Change
+$0.02 (+1.34%)
Updated
Oct 14 closing price
Capitalization
10.6M
Intraday Buy/Sell Signals
Interact to see
Advertisement

APLT vs KALA

Header iconAPLT vs KALA Comparison
Open Charts APLT vs KALABanner chart's image
Applied Therapeutics
Price$1.15
Change+$0.01 (+0.88%)
Volume$2.83M
Capitalization165.61M
Kala BIO
Price$1.51
Change+$0.02 (+1.34%)
Volume$418.57K
Capitalization10.6M
APLT vs KALA Comparison Chart in %
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLT vs. KALA commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Hold and KALA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (APLT: $1.15 vs. KALA: $1.51)
Brand notoriety: APLT and KALA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 48% vs. KALA: 32%
Market capitalization -- APLT: $165.61M vs. KALA: $10.6M
APLT [@Biotechnology] is valued at $165.61M. KALA’s [@Biotechnology] market capitalization is $10.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileKALA’s FA Score has 0 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • KALA’s FA Score: 0 green, 5 red.
According to our system of comparison, APLT is a better buy in the long-term than KALA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 8 TA indicator(s) are bullish while KALA’s TA Score has 5 bullish TA indicator(s).

  • APLT’s TA Score: 8 bullish, 3 bearish.
  • KALA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APLT is a better buy in the short-term than KALA.

Price Growth

APLT (@Biotechnology) experienced а +7.48% price change this week, while KALA (@Biotechnology) price change was -7.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

APLT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLT($166M) has a higher market cap than KALA($10.6M). APLT YTD gains are higher at: 34.314 vs. KALA (-78.242). KALA has higher annual earnings (EBITDA): -31.92M vs. APLT (-110.99M). KALA (31.9M) and APLT (30.4M) have equal amount of cash in the bank . APLT has less debt than KALA: APLT (2.6M) vs KALA (29.9M). APLT has higher revenues than KALA: APLT (121K) vs KALA (0).
APLTKALAAPLT / KALA
Capitalization166M10.6M1,566%
EBITDA-110.99M-31.92M348%
Gain YTD34.314-78.242-44%
P/E RatioN/AN/A-
Revenue121K0-
Total Cash30.4M31.9M95%
Total Debt2.6M29.9M9%
FUNDAMENTALS RATINGS
APLT vs KALA: Fundamental Ratings
APLT
KALA
OUTLOOK RATING
1..100
3270
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3599
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KALA's Valuation (65) in the Pharmaceuticals Major industry is in the same range as APLT (80) in the null industry. This means that KALA’s stock grew similarly to APLT’s over the last 12 months.

KALA's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as APLT (100) in the null industry. This means that KALA’s stock grew similarly to APLT’s over the last 12 months.

APLT's SMR Rating (99) in the null industry is in the same range as KALA (100) in the Pharmaceuticals Major industry. This means that APLT’s stock grew similarly to KALA’s over the last 12 months.

APLT's Price Growth Rating (35) in the null industry is somewhat better than the same rating for KALA (99) in the Pharmaceuticals Major industry. This means that APLT’s stock grew somewhat faster than KALA’s over the last 12 months.

KALA's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as APLT (100) in the null industry. This means that KALA’s stock grew similarly to APLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLTKALA
RSI
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 8 days ago
84%
Momentum
ODDS (%)
Bullish Trend 8 days ago
87%
Bearish Trend 8 days ago
90%
MACD
ODDS (%)
Bullish Trend 8 days ago
87%
Bearish Trend 8 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 8 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
90%
Bullish Trend 27 days ago
78%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
82%
Aroon
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 8 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACSAF79.03N/A
N/A
ACS Actividades De Construccion Y Servicios SA
HELOF0.09N/A
N/A
WINSHEAR GOLD CORP.
CUCSF0.55N/A
N/A
China Communications Services Corp., Ltd.
AUCTF8.96N/A
N/A
AUCNET INC.
EMCGF11.34N/A
N/A
EMBRACE CHANGE ACQUISITION CORP.

APLT and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLT has been loosely correlated with MLTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APLT jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
+0.88%
MLTX - APLT
36%
Loosely correlated
-4.88%
KALA - APLT
35%
Loosely correlated
+1.34%
LRMR - APLT
33%
Loosely correlated
-8.24%
CRNX - APLT
32%
Poorly correlated
-0.86%
AMGXF - APLT
32%
Poorly correlated
N/A
More

KALA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALA has been closely correlated with MLTX. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if KALA jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
+1.34%
MLTX - KALA
89%
Closely correlated
-4.88%
IOBT - KALA
73%
Closely correlated
+10.52%
ABCZF - KALA
42%
Loosely correlated
N/A
LRMR - KALA
41%
Loosely correlated
-8.24%
AUPH - KALA
39%
Loosely correlated
+1.17%
More